In conclusion, our results demonstrated that 16 miRNAs were able to correctly classify tumors into tumor subtypes (PAX3/FOXO1-positive ARMS and translocation-negative RMS) and may be useful to diagnose RMS. Here, PAX3 is linked to neoplasm.